Bristol-Myers, Watson Settle Pravastatin Suit
Tuesday, U.S. District Judge T. John Ward signed off on a stipulated order saying that Slovenian generic drug maker LEK D.D.'s claims against Bristol-Myers Squibb and Watson have been dismissed with prejudice, as were the defendants' claims against LEK.
In filing with the U.S. Securities and Exchange Commission, Bristol-Myers Squibb...
To view the full article, register now.